SynthesisBMC nephrology2017

Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials.

Yifeng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.